SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
7692883
Source:
http://linkedlifedata.com/resource/pubmed/id/7692883
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0019704
,
umls-concept:C0021747
,
umls-concept:C0043474
,
umls-concept:C0132326
,
umls-concept:C0205195
,
umls-concept:C0598312
,
umls-concept:C1332714
pubmed:issue
9
pubmed:dateCreated
1993-12-3
pubmed:abstractText
To determine whether synergistic inhibition of HIV-1 replication would result from the in vitro use of nevirapine in combination with zidovudine, interferon (IFN)-alpha 2C, and CD4 immunoadhesin.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/AI 32907
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8710219
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/CD4 Immunoadhesins
,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Reverse Transcriptase
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon Type I
,
http://linkedlifedata.com/resource/pubmed/chemical/Nevirapine
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Zidovudine
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0269-9370
pubmed:author
pubmed-author:BrewsterFF
,
pubmed-author:GrobPP
,
pubmed-author:KoupR ARA
,
pubmed-author:SullivanJ LJL
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1181-4
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:7692883-Antiviral Agents
,
pubmed-meshheading:7692883-CD4 Immunoadhesins
,
pubmed-meshheading:7692883-Drug Synergism
,
pubmed-meshheading:7692883-Feasibility Studies
,
pubmed-meshheading:7692883-HIV Reverse Transcriptase
,
pubmed-meshheading:7692883-HIV-1
,
pubmed-meshheading:7692883-Humans
,
pubmed-meshheading:7692883-Interferon Type I
,
pubmed-meshheading:7692883-Nevirapine
,
pubmed-meshheading:7692883-Pyridines
,
pubmed-meshheading:7692883-Recombinant Proteins
,
pubmed-meshheading:7692883-Reverse Transcriptase Inhibitors
,
pubmed-meshheading:7692883-Virus Replication
,
pubmed-meshheading:7692883-Zidovudine
pubmed:year
1993
pubmed:articleTitle
Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin.
pubmed:affiliation
University of Massachusetts Medical School, Department of Pediatrics, Worcester.
pubmed:publicationType
Journal Article
,
In Vitro
,
Research Support, U.S. Gov't, P.H.S.
,
Research Support, Non-U.S. Gov't